Skip to main content
. 2022 Jun 30;27(2):101–111. doi: 10.15430/JCP.2022.27.2.101

Figure 2. The GO term enrichment analysis for differentially expressed genes in the DATS-treated MCF-10A human mammary epithelial cell line and the SK-BR-3 human breast cancer cell line.

Figure 2

The GO term enrichment analysis of (A) upregulated or (B) downregulated genes by DATS treatment in MCF-10A (upper panel) and SK-BR-3 (lower panel) cell lines. DATS, diallyl trisulfide; GO, Gene Ontology.